tiprankstipranks
Biorestorative Therapies, Inc. (BRTX)
:BRTX
US Market

BioRestorative Therapies (BRTX) Income Statement

Compare
185 Followers

BioRestorative Therapies Income Statement

Last quarter (Q3 2024), BioRestorative Therapies's total revenue was $233.60K, an increase of 660.91% from the same quarter last year. In Q3, BioRestorative Therapies's net income was $-1.09M. See BioRestorative Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 145.80K$ 119.80K$ 46.00K$ 77.00K$ 130.00K
Gross Profit
$ 145.80K$ -160.87K$ -159.21K$ 77.00K$ 130.00K
Operating Expenses
$ 15.37M$ 18.98M$ 26.35M$ 2.83M$ 8.56M
Depreciation and Amortization
$ 165.74K$ 120.54K$ 205.21K$ 151.96K$ 217.45K
EBITDA
$ -15.06M$ -18.85M$ -26.22M$ -9.48M$ -9.29M
Operating Income
$ -15.22M$ -18.97M$ -26.31M$ -2.75M$ -8.43M
Other Income/Expenses
$ 4.80M$ 5.75M$ -18.00M$ -8.52M$ -6.22M
Pretax Income
$ -10.42M$ -18.49M$ -44.30M$ -11.27M$ -14.65M
Net Income
$ -10.42M$ -18.02M$ -29.94M$ -12.25M$ -17.92M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.47$ -4.98$ -25.21$ -31.05$ -3.22K
Diluted EPS
$ -2.47$ -4.98$ -25.21$ -31.05$ -3.22K
Weighted Average Shares Outstanding
4.22M 3.62M 1.19M 394.70K-
Weighted Average Shares Outstanding (Diluted)
4.22M 3.62M 1.19M 394.70K-
Currency in USD

BioRestorative Therapies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis